Sublethal RNA oxidation as a mechanism for neurodegenerative disease

International Journal of Molecular Sciences

Volumn 9, Issue 5, 2008, Pages 789-806

  Castellani, Rudy J ^a   Nunomura, Akihiko ^b   Rolston, Raj K ^c   Moreira, Paula I ^d   Takeda, Atsushi ^e   Perry, George ^c,f   Smith, Mark A ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f University of San Antonio   (United States)

Author keywords

8 oxoguanosine; Alzheimer disease; Neurodegeneration; Oxidative damage; Parkinson disease; RNA

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN D; CALPAIN; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GUANOSINE DIPHOSPHATE; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; MESSENGER RNA; PROTEIN P53; RIBOSOME RNA; RNA; RNA POLYMERASE; SINGLE STRANDED RNA; TAU PROTEIN; TRANSFER RNA; Y BOX BINDING PROTEIN 1;

ALZHEIMER DISEASE; CHRONIC DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DNA DAMAGE; GENE EXPRESSION REGULATION; GENE MUTATION; GENOME; HUMAN; HYDROGEN BOND; LEWY BODY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRION DISEASE; PROTEIN RNA BINDING; REVIEW;

EID: 44649138016     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms9050789     Document Type: Review

References (119)

1. Hirtz, D.; Thurman, D. J.; Gwinn-Hardy, K.; Mohamed, M.; Chaudhuri, A. R.; Zalutsky, R. How common are the "common" neurologic disorders? Neurology 2007, 68, 326-337.
2. Sayre, L. M.; Smith, M. A.; Perry, G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001, 8, 721-738.
3. Ischiropoulos, H.; Beckman, J. S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 2003, 111, 163-169.
4. Jenner, P. Oxidative stress in Parkinson's disease. Ann. Neurol. 2003, 53 Suppl 3, S26-36; discussion S36-28.
5. Andersen, J. K. Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 2004, 10 Suppl, S18-25.
6. Barnham, K. J.; Masters, C. L.; Bush, A. I. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004, 3, 205-214.
7. Barber, S. C.; Mead, R. J.; Shaw, P. J. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta 2006, 1762, 1051-1067.
8. Lin, M. T.; Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443, 787-795.
9. Nunomura, A.; Castellani, R. J.; Zhu, X.; Moreira, P. I.; Perry, G.; Smith, M. A. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65, 631-641.
10. Nunomura, A.; Perry, G.; Pappolla, M. A.; Wade, R.; Hirai, K.; Chiba, S.; Smith, M. A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 1999, 19, 1959-1964.
11. Li, Z.; Wu, J.; Deleo, C. J. RNA damage and surveillance under oxidative stress. IUBMB life 2006, 58, 581-588.
12. Bregeon, D.; Sarasin, A. Hypothetical role of RNA damage avoidance in preventing human disease. Mutat. Res. 2005, 577, 293-302.
13. Moreira, P. I.; Nunomura, A.; Nakamura, M.; Takeda, A.; Shenk, J. C.; Aliev, G.; Smith, M. A.; Perry, G. Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 2008, 44, 1493-1505.
14. Hofer, T.; Seo, A. Y.; Prudencio, M.; Leeuwenburgh, C. A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration. Biol. Chem. 2006, 387, 103-111.
15. Shen, Z.; Wu, W.; Hazen, S. L. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry (Mosc). 2000, 39, 5474-5482.
16. Wamer, W. G.; Wei, R. R. In vitro photooxidation of nucleic acids by ultraviolet A radiation. Photochem. Photobiol. 1997, 65, 560-563.
17. Hofer, T.; Badouard, C.; Bajak, E.; Ravanat, J. L.; Mattsson, A.; Cotgreave, I. A. Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA. Biol. Chem. 2005, 386, 333-337.
18. Fiala, E. S.; Conaway, C. C.; Mathis, J. E. Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res. 1989, 49, 5518-5522.
19. Weimann, A.; Belling, D.; Poulsen, H. E. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry. Nucleic Acids Res 2002, 30, E7.
20. Szymanski, M.; Barciszewska, M. Z.; Erdmann, V. A.; Barciszewski, J. A new frontier for molecular medicine: noncoding RNAs. Biochim. Biophys. Acta 2005, 1756, 65-75.
21. Costa, F. F. Non-coding RNAs: new players in eukaryotic biology. Gene 2005, 357, 83-94.
22. Cao, X.; Yeo, G.; Muotri, A. R.; Kuwabara, T.; Gage, F. H. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 2006, 29, 77-103.
23. Mehler, M. F.; Mattick, J. S. Non-coding RNAs in the nervous system. J. Physiol. 2006, 575, 333-341.
24. Taft, R. J.; Pheasant, M.; Mattick, J. S. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 2007, 29, 288-299.
25. Perkins, D. O.; Jeffries, C.; Sullivan, P. Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol. Psychiatry 2005, 10, 69-78.
26. Taylor, J. P.; Hardy, J.; Fischbeck, K. H. Toxic proteins in neurodegenerative disease. Science 2002, 296, 1991-1995.
27. van Leeuwen, F. W.; de Kleijn, D. P.; van den Hurk, H. H.; Neubauer, A.; Sonnemans, M. A.; Sluijs, J. A.; Koycu, S.; Ramdjielal, R. D.; Salehi, A.; Martens, G. J.; Grosveld, F. G.; Peter, J.; Burbach, H.; Hol, E. M. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 1998, 279, 242-247.
28. Lee, J. W.; Beebe, K.; Nangle, L. A.; Jang, J.; Longo-Guess, C. M.; Cook, S. A.; Davisson, M. T.; Sundberg, J. P.; Schimmel, P.; Ackerman, S. L. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443, 50-55.
29. Evans, M. D.; Dizdaroglu, M.; Cooke, M. S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004, 567, 1-61.
30. Cooke, M. S.; Olinski, R.; Evans, M. D. Does measurement of oxidative damage to DNA have clinical significance? Clin. Chim. Acta 2006, 365, 30-49.
31. Kasai, H.; Crain, P. F.; Kuchino, Y.; Nishimura, S.; Ootsuyama, A.; Tanooka, H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 1986, 7, 1849-1851.
32. Ames, B. N.; Gold, L. S. Endogenous mutagens and the causes of aging and cancer. Mutat. Res. 1991, 250, 3-16.
33. Yanagawa, H.; Ogawa, Y.; Ueno, M. Redox ribonucleosides. Isolation and characterization of 5-hydroxyuridine, 8-hydroxyguanosine, and 8-hydroxyadenosine from Torula yeast RNA. J. Biol. Chem. 1992, 267, 13320-13326.
34. Schneider, J. E., Jr.; Phillips, J. R.; Pye, Q.; Maidt, M. L.; Price, S.; Floyd, R. A. Methylene blue and rose bengal photoinactivation of RNA bacteriophages: comparative studies of 8-oxoguanine formation in isolated RNA. Arch. Biochem. Biophys. 1993, 301, 91-97.
35. Rhee, Y.; Valentine, M. R.; Termini, J. Oxidative base damage in RNA detected by reverse transcriptase. Nucleic Acids Res 1995, 23, 3275-3282.
36. Barciszewski, J.; Barciszewska, M. Z.; Siboska, G.; Rattan, S. I.; Clark, B. F. Some unusual nucleic acid bases are products of hydroxyl radical oxidation of DNA and RNA. Mol. Biol. Rep. 1999, 26, 231-238.
37. Yin, B.; Whyatt, R. M.; Perera, F. P.; Randall, M. C.; Cooper, T. B.; Santella, R. M. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic. Biol. Med. 1995, 18, 1023-1032.
38. Park, E. M.; Shigenaga, M. K.; Degan, P.; Korn, T. S.; Kitzler, J. W.; Wehr, C. M.; Kolachana, P.; Ames, B. N. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 3375-3379.
39. Zhang, J.; Perry, G.; Smith, M. A.; Robertson, D.; Olson, S. J.; Graham, D. G.; Montine, T. J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 1999, 154, 1423-1429.
40. Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E. K.; Jones, P. K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C. S.; Petersen, R. B.; Smith, M. A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60, 759-767.
41. Nunomura, A.; Perry, G.; Pappolla, M. A.; Friedland, R. P.; Hirai, K.; Chiba, S.; Smith, M. A. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 2000, 59, 1011-1017.
42. Nunomura, A.; Chiba, S.; Kosaka, K.; Takeda, A.; Castellani, R. J.; Smith, M. A.; Perry, G. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport 2002, 13, 2035-2039.
43. Guentchev, M.; Siedlak, S. L.; Jarius, C.; Tagliavini, F.; Castellani, R. J.; Perry, G.; Smith, M. A.; Budka, H. Oxidative damage to nucleic acids in human prion disease. Neurobiol. Dis. 2002, 9, 275-281.
44. Hayashi, M.; Arai, N.; Satoh, J.; Suzuki, H.; Katayama, K.; Tamagawa, K.; Morimatsu, Y. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J. Child Neurol. 2002, 17, 725-730.
45. Nunomura, A.; Chiba, S.; Lippa, C. F.; Cras, P.; Kalaria, R. N.; Takeda, A.; Honda, K.; Smith, M. A.; Perry, G. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol. Dis. 2004, 17, 108-113.
46. Petersen, R. B.; Siedlak, S. L.; Lee, H. G.; Kim, Y. S.; Nunomura, A.; Tagliavini, F.; Ghetti, B.; Cras, P.; Moreira, P. I.; Castellani, R. J.; Guentchev, M.; Budka, H.; Ironside, J. W.; Gambetti, P.; Smith, M. A.; Perry, G. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol 2005, 110, 232-238.
47. Hayashi, M.; Araki, S.; Kohyama, J.; Shioda, K.; Fukatsu, R. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev. 2005, 27, 34-38.
48. Tateyama, M.; Takeda, A.; Onodera, Y.; Matsuzaki, M.; Hasegawa, T.; Nunomura, A.; Hirai, K.; Perry, G.; Smith, M. A.; Itoyama, Y. Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles. Acta Neuropathol. (Berl). 2003, 105, 581-585.
49. Martinet, W.; de Meyer, G. R.; Herman, A. G.; Kockx, M. M. Reactive oxygen species induce RNA damage in human atherosclerosis. Eur. J. Clin. Invest. 2004, 34, 323-327.
50. Hofer, T.; Marzetti, E.; Xu, J.; Seo, A. Y.; Gulec, S.; Knutson, M. D.; Leeuwenburgh, C.; Dupont-Versteegden, E. E. Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy. Exp. Gerontol. 2008, in press.
51. Shan, X.; Tashiro, H.; Lin, C. L. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 2003, 23, 4913-4921.
52. Honda, K.; Smith, M. A.; Zhu, X.; Baus, D.; Merrick, W. C.; Tartakoff, A. M.; Hattier, T.; Harris, P. L.; Siedlak, S. L.; Fujioka, H.; Liu, Q.; Moreira, P. I.; Miller, F. P.; Nunomura, A.; Shimohama, S.; Perry, G. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J. Biol. Chem. 2005, 280, 20978-20986.
53. Ding, Q.; Markesbery, W. R.; Chen, Q.; Li, F.; Keller, J. N. Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci. 2005, 25, 9171-9175.
54. Ding, Q.; Markesbery, W. R.; Cecarini, V.; Keller, J. N. Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem. Res. 2006, 31, 705-710.
55. Shan, X.; Lin, C. L. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol. Aging 2006, 27, 657-662.
56. Abe, T.; Tohgi, H.; Isobe, C.; Murata, T.; Sato, C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J. Neurosci. Res. 2002, 70, 447-450.
57. Kikuchi, A.; Takeda, A.; Onodera, H.; Kimpara, T.; Hisanaga, K.; Sato, N.; Nunomura, A.; Castellani, R. J.; Perry, G.; Smith, M. A.; Itoyama, Y. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol. Dis. 2002, 9, 244-248.
58. Abe, T.; Isobe, C.; Murata, T.; Sato, C.; Tohgi, H. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease. Neurosci. Lett. 2003, 336, 105-108.
59. Liu, J.; Head, E.; Gharib, A. M.; Yuan, W.; Ingersoll, R. T.; Hagen, T. M.; Cotman, C. W.; Ames, B. N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 2356-2361.
60. Row, B. W.; Liu, R.; Xu, W.; Kheirandish, L.; Gozal, D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am. J. Respir. Crit. Care Med. 2003, 167, 1548-1553.
61. Yamaguchi, H.; Kajitani, K.; Dan, Y.; Furuichi, M.; Ohno, M.; Sakumi, K.; Kang, D.; Nakabeppu, Y. MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Cell Death Differ. 2006, 13, 551-563.
62. Foksinski, M.; Rozalski, R.; Guz, J.; Ruszkowska, B.; Sztukowska, P.; Piwowarski, M.; Klungland, A.; Olinski, R. Urinary excretion of DNA repair products correlates with metabolic rates as well as with maximum life spans of different mammalian species. Free Radic. Biol. Med. 2004, 37, 1449-1454.
63. Javitch, J. A.; D'Amato, R. J.; Strittmatter, S. M.; Snyder, S. H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 2173-2177.
64. Wang, Q.; Yu, S.; Simonyi, A.; Sun, G. Y.; Sun, A. Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol. Neurobiol. 2005, 31, 3-16.
65. Kajitani, K.; Yamaguchi, H.; Dan, Y.; Furuichi, M.; Kang, D.; Nakabeppu, Y. MTH1, an oxidized purine nucleoside triphosphatase, suppresses the accumulation of oxidative damage of nucleic acids in the hippocampal microglia during kainate-induced excitotoxicity. J. Neurosci. 2006, 26, 1688-1698.
66. Rosen, D. R.; Siddique, T.; Patterson, D.; Figlewicz, D. A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O'Regan, J. P.; Deng, H. X.; et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362, 59-62.
67. Gurney, M. E.; Pu, H.; Chiu, A. Y.; Dal Canto, M. C.; Polchow, C. Y.; Alexander, D. D.; Caliendo, J.; Hentati, A.; Kwon, Y. W.; Deng, H. X.; et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264, 1772-1775.
68. Chang, Y.; Shan, X.; Lin, C. L. RNA oxidation is an early event preceding motor neuron death in ALS. Soc. Neurosci. Abstr. 2004, 96.93.
69. Ding, Q.; Dimayuga, E.; Markesbery, W. R.; Keller, J. N. Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures. J. Neurochem. 2004, 91, 1211-1218.
70. Shan, X.; Chang, Y.; Lin, C. L. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression. FASEB J. 2007, 21, 2753-2764.
71. Ding, Q.; Cecarini, V.; Keller, J. N. Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications. Trends Neurosci. 2007, 30, 31-36.
72. Keller, J. N.; Schmitt, F. A.; Scheff, S. W.; Ding, Q.; Chen, Q.; Butterfield, D. A.; Markesbery, W. R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64, 1152-1156.
73. Butterfield, D. A.; Reed, T. T.; Perluigi, M.; De Marco, C.; Coccia, R.; Keller, J. N.; Markesbery, W. R.; Sultana, R. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res. 2007, 1148, 243-248.
74. Pratico, D.; Clark, C. M.; Liun, F.; Rokach, J.; Lee, V. Y.; Trojanowski, J. Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 2002, 59, 972-976.
75. Migliore, L.; Fontana, I.; Trippi, F.; Colognato, R.; Coppede, F.; Tognoni, G.; Nucciarone, B.; Siciliano, G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol. Aging 2005, 26, 567-573.
76. Rinaldi, P.; Polidori, M. C.; Metastasio, A.; Mariani, E.; Mattioli, P.; Cherubini, A.; Catani, M.; Cecchetti, R.; Senin, U.; Mecocci, P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 2003, 24, 915-919.
77. Guidi, I.; Galimberti, D.; Lonati, S.; Novembrino, C.; Bamonti, F.; Tiriticco, M.; Fenoglio, C.; Venturelli, E.; Baron, P.; Bresolin, N.; Scarpini, E. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2006, 27, 262-269.
78. Moreira, P. I.; Zhu, X.; Nunomura, A.; Smith, M. A.; Perry, G. Therapeutic options in Alzheimer's disease. Expert Rev. Neurother. 2006, 6, 897-910.
79. Liu, Q.; Xie, F.; Rolston, R.; Moreira, P. I.; Nunomura, A.; Zhu, X.; Smith, M. A.; Perry, G. Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Rev. Med. Chem. 2007, 7, 171-180.
80. Sayre, L. M.; Perry, G.; Smith, M. A. In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders. Methods Enzymol. 1999, 309, 133-152.
81. Smith, M. A.; Perry, G.; Richey, P. L.; Sayre, L. M.; Anderson, V. E.; Beal, M. F.; Kowall, N. Oxidative damage in Alzheimer's. Nature 1996, 382, 120-121.
82. Sayre, L. M.; Zelasko, D. A.; Harris, P. L.; Perry, G.; Salomon, R. G.; Smith, M. A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 1997, 68, 2092-2097.
83. Casadesus, G.; Smith, M. A.; Basu, S.; Hua, J.; Capobianco, D. E.; Siedlak, S. L.; Zhu, X.; Perry, G. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease. Mol. Neurodegener. 2007, 2, 2.
84. Castellani, R. J.; Harris, P. L.; Sayre, L. M.; Fujii, J.; Taniguchi, N.; Vitek, M. P.; Founds, H.; Atwood, C. S.; Perry, G.; Smith, M. A. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic. Biol. Med. 2001, 31, 175-180.
85. Coyle, J. T.; Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262, 689-695.
86. Mattson, M. P.; Chan, S. L.; Duan, W. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 2002, 82, 637-672.
87. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59, 1609-1623.
88. Joenje, H. Genetic toxicology of oxygen. Mutat. Res. 1989, 219, 193-208.
89. Takahashi, M. A.; Asada, K. Superoxide anion permeability of phospholipid membranes and chloroplast thylakoids. Arch. Biochem. Biophys. 1983, 226, 558-566.
90. Schubert, J.; Wilmer, J. W. Does hydrogen peroxide exist "free" in biological systems? Free Radic. Biol. Med. 1991, 11, 545-555.
91. Hirai, K.; Aliev, G.; Nunomura, A.; Fujioka, H.; Russell, R. L.; Atwood, C. S.; Johnson, A. B.; Kress, Y.; Vinters, H. V.; Tabaton, M.; Shimohama, S.; Cash, A. D.; Siedlak, S. L.; Harris, P. L.; Jones, P. K.; Petersen, R. B.; Perry, G.; Smith, M. A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001, 21, 3017-3023.
92. Perry, G.; Nunomura, A.; Cash, A. D.; Taddeo, M. A.; Hirai, K.; Aliev, G.; Avila, J.; Wataya, T.; Shimohama, S.; Atwood, C. S.; Smith, M. A. Reactive oxygen: its sources and significance in Alzheimer disease. J. Neural Transm. Suppl. 2002, 69-75.
93. Perry, G.; Nunomura, A.; Hirai, K.; Zhu, X.; Perez, M.; Avila, J.; Castellani, R. J.; Atwood, C. S.; Aliev, G.; Sayre, L. M.; Takeda, A.; Smith, M. A. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 2002, 33, 1475-1479.
94. Smith, M. A.; Nunomura, A.; Zhu, X.; Takeda, A.; Perry, G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid. Redox Signal. 2000, 2, 413-420.
95. Gu, G.; Reyes, P. E.; Golden, G. T.; Woltjer, R. L.; Hulette, C.; Montine, T. J.; Zhang, J. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 2002, 61, 634-639.
96. Schapira, A. H.; Cooper, J. M.; Dexter, D.; Clark, J. B.; Jenner, P.; Marsden, C. D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 1990, 54, 823-827.
97. Sofic, E.; Riederer, P.; Heinsen, H.; Beckmann, H.; Reynolds, G. P.; Hebenstreit, G.; Youdim, M. B. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 1988, 74, 199-205.
98. Berg, D.; Roggendorf, W.; Schroder, U.; Klein, R.; Tatschner, T.; Benz, P.; Tucha, O.; Preier, M.; Lange, K. W.; Reiners, K.; Gerlach, M.; Becker, G. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 2002, 59, 999-1005.
99. Ishibashi, T.; Hayakawa, H.; Ito, R.; Miyazawa, M.; Yamagata, Y.; Sekiguchi, M. Mammalian enzymes for preventing transcriptional errors caused by oxidative damage. Nucleic Acids Res 2005, 33, 3779-3784.
100. Taddei, F.; Hayakawa, H.; Bouton, M.; Cirinesi, A.; Matic, I.; Sekiguchi, M.; Radman, M. Counteraction by MutT protein of transcriptional errors caused by oxidative damage. Science 1997, 278, 128-130.
101. Tanaka, M.; Chock, P. B.; Stadtman, E. R. Oxidized messenger RNA induces translation errors. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 66-71.
102. Gong, X.; Tao, R.; Li, Z. Quantification of RNA damage by reverse transcription polymerase chain reactions. Anal. Biochem. 2006, 357, 58-67.
103. Bellacosa, A.; Moss, E. G. RNA repair: damage control. Curr. Biol. 2003, 13, R482-484.
104. Deutscher, M. P. Degradation of RNA in bacteria: comparison of mRNA and stable RNA. Nucleic Acids Res 2006, 34, 659-666.
105. Sheth, U.; Parker, R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003, 300, 805-808.
106. Sweet, T. J.; Boyer, B.; Hu, W.; Baker, K. E.; Coller, J. Microtubule disruption stimulates P-body formation. RNA 2007, 13, 493-502.
107. Kedersha, N.; Stoecklin, G.; Ayodele, M.; Yacono, P.; Lykke-Andersen, J.; Fritzler, M. J.; Scheuner, D.; Kaufman, R. J.; Golan, D. E.; Anderson, P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 2005, 169, 871-884.
108. Aas, P. A.; Otterlei, M.; Falnes, P. O.; Vagbo, C. B.; Skorpen, F.; Akbari, M.; Sundheim, O.; Bjoras, M.; Slupphaug, G.; Seeberg, E.; Krokan, H. E. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 2003, 421, 859-863.
109. Krokan, H. E.; Kavli, B.; Slupphaug, G. Novel aspects of macromolecular repair and relationship to human disease. J. Mol. Med. 2004, 82, 280-297.
110. Nakabeppu, Y.; Tsuchimoto, D.; Ichinoe, A.; Ohno, M.; Ide, Y.; Hirano, S.; Yoshimura, D.; Tominaga, Y.; Furuichi, M.; Sakumi, K. Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei. Ann. N. Y. Acad. Sci. 2004, 1011, 101-111.
111. Hayakawa, H.; Hofer, A.; Thelander, L.; Kitajima, S.; Cai, Y.; Oshiro, S.; Yakushiji, H.; Nakabeppu, Y.; Kuwano, M.; Sekiguchi, M. Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry (Mosc). 1999, 38, 3610-3614.
112. Nakabeppu, Y.; Kajitani, K.; Sakamoto, K.; Yamaguchi, H.; Tsuchimoto, D. MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. DNA Repair (Amst.) 2006, 5, 761-772.
113. Ito, R.; Hayakawa, H.; Sekiguchi, M.; Ishibashi, T. Multiple enzyme activities of Escherichia coli MutT protein for sanitization of DNA and RNA precursor pools. Biochemistry (Mosc). 2005, 44, 6670-6674.
114. Furuta, A.; Iida, T.; Nakabeppu, Y.; Iwaki, T. Expression of hMTH1 in the hippocampi of control and Alzheimer's disease. Neuroreport 2001, 12, 2895-2899.
115. Shimura-Miura, H.; Hattori, N.; Kang, D.; Miyako, K.; Nakabeppu, Y.; Mizuno, Y. Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease. Ann. Neurol. 1999, 46, 920-924.
116. Hayakawa, H.; Kuwano, M.; Sekiguchi, M. Specific binding of 8-oxoguanine-containing RNA to polynucleotide phosphorylase protein. Biochemistry (Mosc). 2001, 40, 9977-9982.
117. Hayakawa, H.; Sekiguchi, M. Human polynucleotide phosphorylase protein in response to oxidative stress. Biochemistry (Mosc). 2006, 45, 6749-6755.
118. Hayakawa, H.; Uchiumi, T.; Fukuda, T.; Ashizuka, M.; Kohno, K.; Kuwano, M.; Sekiguchi, M. Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry (Mosc). 2002, 41, 12739-12744.
119. Yang, W. H.; Bloch, D. B. Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 2007, 13, 704-712.